Photopheresis Products Market Research Report 2016 Photopheresis Products Market - Global Industry An

Photopheresis Products Market - Global Industry Analysis, Size,
Share, Growth, Trends, and Forecast 2016 – 2024
Global Photopheresis Products Market: Overview
The photopheresis products market is mainly driven by growing Graft versus host disease conditions
globally. Furthermore the rising coverage of healthcare and increasing in transplantations expected to
grow photopheresis products market growth. However, the market growth is hindered by lack of many
photopheresis treatment centers and high cost involved in therapy. In the U.S., ECP therapy costs
around US$8000/treatment and every individual has to take the treatment for every two weeks and
continue the same procedure for one year to complete the treatment. According to research article,
globally, around 26% to 36% recipients of full matched sibling donor grafts suffer from acute graft
versus host disease conditions. Photopheresis therapy is a U.S FDA approved treatment to treat
cutaneous T-cell lymphoma conditions.
This 133 page report gives readers a comprehensive overview of the Photopheresis Products market
Browse through 22 data tables and 78 figures to unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/photopheresis-products-market.html
However, it is most commonly used in treating graft versus host disease conditions. Furthermore, in
2016, Swedish government has given reimbursement for lung transplantations by using photopheresis
therapy. Currently few clinical trials are undergoing on photopheresis therapy to explore its benefits to
treat autoimmune disease conditions. Treatment of autoimmune diseases using photopheresis
therapy is still in nascent phase. Mallinckrodt pharmaceuticals is actively conducting clinical trials on
novel therapeutic indications like Cohn’s disease, multiple sclerosis conditions and more over. In 2015,
Therakos Inc., was acquired by Mallinckrodt to strengthen its revenue generation from hospital
segment. Based on the product type, photopheresis products are segmented into open systems and
closed systems. Closed systems are mostly used globally to treat various disease conditions and these
are technologically advanced systems than the open systems. In USA, closed systems dominates the
market and they are approved by U.S FDA to treat cutaneous T-cell lymphoma conditions. In Europe,
both closed systems and open systems are commonly preferred to treat various disease conditions.
Global Photopheresis Products Market: Scope of the Report
The report is a combination of primary and secondary research. Primary research formed the bulk of
our research efforts, with information collected from telephonic interviews and interactions via e-mail.
Secondary research involved study of company websites, annual reports, press releases, stock
analysis presentations, and various national and international databases. The report provides market
size in terms of US$ Mn for each segment for the period from 2016 to 2024, considering the macro
and micro-environmental factors. Growth rates for each segment within the photopheresis products
market have been determined after a thorough analysis of past trends, demographics, future trends,
technological developments, vaccination expenditure, and regulatory requirements.